News for Acacia Pharma Group plc (ACPH.BR)

Published at

Oct 10, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight

The need for antiemetic drugs, which help prevent or relieve nausea and vomiting, is growing for several reasons. A key factor is the rising incidence of...

VTRSV VTRS.MX VTRS VIA.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE HKMPY HKMPF HIK.L EGRX ALPMY ALPMF 4503N.MX NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK LBPSW LBPS FRPRF DDDD.L ANIP ACPH.BR ACPGF 6MK.DE 0PNT.L 0K9E.L JNJ DJNJ3.BA DJNJ2.BA

Read more →
Published at

Mar 13, 2023 11:50 AM

by globenewswire.com

positive

positive

Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results

• Q4 2022 net income was $0.63 per basic and $0.62 per diluted share and adjusted non-GAAP net income was $1.11 per basic and $1.10 per diluted share1 •...

FRGAP EGRX ACPH.BR ACPGF 0PNT.L

Read more →
Published at

Feb 20, 2023 5:15 AM

by prnewswire.com

mixed

mixed

Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth - Technavio

/PRNewswire/ -- The Cancer Supportive Care Market by Therapeutic Area, Distribution Channel, and Geography - Forecast and Analysis 2023-2027 report has been...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA KYKOF HRTX GSK.L GSK GS7.DE GLAXF BAX.MX BAX ACPH.BR ACPGF 4151.T 0QK8.L 0PNT.L 0K9E.L 0J4V.L SUNPHARMA-BL.NS SKXJF AMGN.MX AMGN.BA AMGN AMG.DE 6417.T

Read more →
Published at

Nov 9, 2022 12:50 PM

by globenewswire.com

mixed

mixed

Correcting & Replacing: Eagle Pharmaceuticals Reports Third Quarter 2022 Results

WOODCLIFF LAKE, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. is re-issuing in its entirety its earnings press release for the...

FRGAP EGRX ACPH.BR ACPGF 0PNT.L

Read more →
Published at

Nov 7, 2022 12:50 PM

by globenewswire.com

mixed

mixed

Eagle Pharmaceuticals Reports Third Quarter 2022 Results

Q3 2022 net loss was $(0.27) per basic and diluted share and adjusted non-GAAP net income was $1.13 per basic and $1.12 per diluted share1Total...

FRGAP EGRX ACPH.BR ACPGF 0PNT.L

Read more →
Published at

Jul 18, 2022 12:50 PM

by globenewswire.com

positive

positive

Eagle Pharmaceuticals Appoints Debra M. Hussain as SVP, Head of Commercial

WOODCLIFF LAKE, N.J., July 18, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced the...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA EGRX ACPH.BR ACPGF 0Q1G.L 0PNT.L

Read more →
Published at

Jul 1, 2022 7:42 AM

by etfdailynews.com

positive

positive

Acacia Pharma Group plc (OTCMKTS:ACPGF) Short Interest Down 52.7% in June

Read Acacia Pharma Group plc (OTCMKTS:ACPGF) Short Interest Down 52.7% in June at ETF Daily News

ACPH.BR ACPGF 0PNT.L

Read more →
Published at

Jun 13, 2022 7:54 AM

by etfdailynews.com

positive

positive

Acacia Pharma Group plc (OTCMKTS:ACPGF) Short Interest Update

Read Acacia Pharma Group plc (OTCMKTS:ACPGF) Short Interest Update at ETF Daily News

ACPH.BR ACPGF 0PNT.L

Read more →
Published at

Jun 9, 2022 1:30 PM

by globenewswire.com

positive

positive

Eagle Pharmaceuticals Completes Acquisition of Acacia Pharma Group plc, Expanding Acute Care Footprint

Adds two U.S. Food and Drug Administration (“FDA”) approved new chemical entities with strong patent protectionBARHEMSYS® (amisulpride for injection) and...

EGRX ACPH.BR ACPGF 0PNT.L

Read more →
Published at

May 15, 2022 8:04 AM

by etfdailynews.com

positive

positive

Acacia Pharma Group plc (OTCMKTS:ACPGF) Short Interest Down 27.7% in April

Read Acacia Pharma Group plc (OTCMKTS:ACPGF) Short Interest Down 27.7% in April at ETF Daily News

ACPH.BR ACPGF 0PNT.L

Read more →
Published at

Jan 28, 2021 7:10 AM

by marketscreener.com

positive

positive

Acacia Pharma : Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less

28 January 2021 Acacia Pharma Launches BYFAVO™ in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less ... | January 28, 2021

PAIOF PA8.SG PA8.MU PA8.F PA8.DE PA8.BE ACPH.BR ACPGF

Read more →